- Home
- FIP vs TSHA Comparison
FIP vs TSHA Comparison
Compare FIP & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIP
- TSHA
- Stock Information
- Founded
- FIP 2021
- TSHA 2019
- Country
- FIP United States
- TSHA United States
- Employees
- FIP N/A
- TSHA N/A
- Industry
- FIP Consumer Electronics/Appliances
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- FIP Industrials
- TSHA Health Care
- Exchange
- FIP Nasdaq
- TSHA Nasdaq
- Market Cap
- FIP 715.0M
- TSHA 728.4M
- IPO Year
- FIP N/A
- TSHA 2020
- Fundamental
- Price
- FIP $7.18
- TSHA $2.74
- Analyst Decision
- FIP Buy
- TSHA Strong Buy
- Analyst Count
- FIP 1
- TSHA 6
- Target Price
- FIP $12.00
- TSHA $8.17
- AVG Volume (30 Days)
- FIP 1.2M
- TSHA 2.8M
- Earning Date
- FIP 08-07-2025
- TSHA 08-15-2025
- Dividend Yield
- FIP 1.67%
- TSHA N/A
- EPS Growth
- FIP N/A
- TSHA N/A
- EPS
- FIP N/A
- TSHA N/A
- Revenue
- FIP $345,123,000.00
- TSHA $7,224,000.00
- Revenue This Year
- FIP $65.61
- TSHA N/A
- Revenue Next Year
- FIP $30.50
- TSHA N/A
- P/E Ratio
- FIP N/A
- TSHA N/A
- Revenue Growth
- FIP 5.70
- TSHA N/A
- 52 Week Low
- FIP $3.10
- TSHA $1.05
- 52 Week High
- FIP $10.01
- TSHA $3.31
- Technical
- Relative Strength Index (RSI)
- FIP 65.88
- TSHA 58.14
- Support Level
- FIP $5.84
- TSHA $2.54
- Resistance Level
- FIP $7.18
- TSHA $2.91
- Average True Range (ATR)
- FIP 0.41
- TSHA 0.17
- MACD
- FIP 0.01
- TSHA 0.01
- Stochastic Oscillator
- FIP 98.18
- TSHA 70.18
About FIP FTAI Infrastructure Inc.
FTAI Infrastructure Inc is engaged in five segments; Railroad segment includes five freight railroads and one switching company that provide rail service to certain manufacturing and production facilities, the Jefferson Terminal segment consists of a multi-modal crude oil and refined products terminal and other related assets. Repauno segment consists of a 1,630-acre deep-water port located along the Delaware River with an underground storage cavern, a new multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities. Power and Gas segment is comprised of an equity method investment in Long Ridge, and Sustainability and Energy Transition segment is comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.